Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Intervalo de año de publicación
1.
Biochem Biophys Res Commun ; 737: 150533, 2024 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-39142138

RESUMEN

Enzyme-mediated lipid oxidation is an important regulatory event in cell signaling, with oxidized lipids being potent signaling molecules that can illicit dramatic changes in cell behavior. For example, peroxidation of an arachidonoyl poly-unsaturated fatty acid by the human enzyme 15-lipoxygenase-2 (15-LOX-2) has been associated with formation of atherosclerotic plaques. Previous work on synthetically oxidized membranes has shown that oxidized lipid tails will change their conformation to facilitate interactions between the peroxide group and the lipid headgroups. However, this phenomenon has not been directly observed for a lipid membrane that has undergone enzyme-catalyzed oxidation. In this study, we report on the structure of a model lipid membrane before and after oxidation by 15-LOX-2. A model lipid membrane monolayer at the air-liquid interface was constructed from 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (SAPC) in a Langmuir trough, and X-ray reflectivity measurements were conducted to determine the electron density profile of the system. Exposure to 15-LOX-2 caused a dramatic change in the SAPC structure, namely a blurred distinction between the lipid tail/head layers and shortening of the average lipid tail length by ∼3 Å. The electron density profile of the oxidized SAPC monolayer is similar to that of a synthetically oxidized substrate mimic. Overall, this reported observation of an enzymatically-oxidized membrane structure in situ is helping to bridge a gap in the literature between structural studies on synthetically oxidized membranes and cellular studies aiming to understand physiological responses.

2.
Res Involv Engagem ; 8(1): 42, 2022 Aug 24.
Artículo en Inglés | MEDLINE | ID: mdl-36002877

RESUMEN

INTRODUCTION: Despite a movement toward the inclusion of patient partners or advisors as part of the research team in all funded studies, few publications have discussed patient engagement from the patient partners' perspective. METHODS: Qualitative interviews were conducted by independent qualitative researchers to collect and summarize the experiences and perspectives of the 16 Patient Partners (PPs) on the study team for PeRson EmPowered Asthma RElief (PREPARE), a large, pragmatic study of 1200 African American/Black (AA/B) and Hispanic/Latinx (H/L) adults with asthma. This study was funded by the Patient-Centered Outcomes Research Institute. RESULTS: This paper, authored by the PPs themselves, summarizes qualitative interview findings. The journey of the PREPARE PPs began with a desire to learn more about asthma and advocate for other individuals with asthma. Many challenges, including intimidation and lack of trust, were overcome as the research team prioritized building a comfortable environment in which PPs' lived experiences, opinions, and cultural beliefs are valued, and in which PP voices are centered and respected. Over time, the PPs gained confidence in expressing ideas and feedback, and in taking ownership of their role as valued members of the research team. The PP experience has had tremendous personal and professional impact on the PPs themselves, while also modeling a change in the way researchers and PPs relate to and partner with each other. CONCLUSION: The partnership between PPs and researchers in the PREPARE study has elevated the PP role from external advisors to integral and empowered members of a collective research team, and the partnership developed and evolved over time.


Patients and caregivers who have lived with a condition have an important and unique perspective researchers should consider. To this end, patients and caregivers have expanded their involvement in the design and conduct of clinical research, joining research teams and being engaged in the research process from start to finish. Researchers have reported on the positive impact that these "patient partners" or "patient advisors" have on research. But few papers report on the impact on the patient partners/advisors from being on a research team.Here we report the lived experiences of the 16 Patient Partners who served on the research team for a large study of 1200 African American/Black (AA/B) and Hispanic/Latinx (H/L) adults with asthma. These Patient Partners offered their input over 7 years, spanning from study design, study conduct, understanding results, to sharing results.To understand the Patient Partners' experiences, we conducted interviews asking about their journey on the research team. Motivations and reasons they became Patient Partners Initial experiences with the research team If and how over time, they became comfortable and developed confidence If and how the research team made them feel valued and respected The personal and professional impact of being a Patient Partner Their advice to researchers and fellow patients considering including or joining as Patient Partners or advisors By reporting the perspectives of these 16 Patient Partners, we hope to support continued movement toward broader and better inclusion of patients and caregivers on research teams.

3.
J Allergy Clin Immunol Pract ; 10(2): 517-524.e2, 2022 02.
Artículo en Inglés | MEDLINE | ID: mdl-34673286

RESUMEN

BACKGROUND: Generally, a short-acting beta-2 agonist (SABA) delivered via metered-dose inhaler (MDI) is recommended for quick relief of asthma symptoms. However, in the PeRson EmPowered Asthma RElief (PREPARE) pragmatic trial, 67% of patients reported having used a nebulizer for SABA administration. OBJECTIVE: To understand preferences, experiences, and decision making regarding the use of nebulizers in Black and Latinx adults with uncontrolled asthma. METHODS: We interviewed 40 of the 1,201 PREPARE patients employing a matrix analysis. Those interviewed were Black (n = 20) and Latinx (n = 20) adults with uncontrolled asthma seeking primary or specialty care in clinics throughout the United States. Data were analyzed used a Rapid Assessment Procedures qualitative methodology, informed by grounded theory. RESULTS: Substudy participants, on average, reported using a nebulizer 3.5 times/wk. Daily use was common, and frequency ranged from less than daily to up to 6 times daily. Nearly all participants reported a longstanding history of nebulizer use. Participants tended to use their nebulizer at home, and some shared it with others in the home. Many reported preferring a nebulizer over an MDI for relief of severe symptoms and to avoid emergency room visits or hospitalizations. The extent to which cost affected nebulizer use varied among participants. CONCLUSIONS: Despite asthma guideline recommendations that MDIs be used rather than nebulizers for SABA administration, nebulizer use was common among PREPARE study participants. Clinicians should explore patients' history and experiences with nebulizer use as part of evaluation of asthma control.


Asunto(s)
Asma , Nebulizadores y Vaporizadores , Administración por Inhalación , Adulto , Asma/tratamiento farmacológico , Broncodilatadores/uso terapéutico , Hospitalización , Humanos , Inhaladores de Dosis Medida
4.
Contemp Clin Trials ; 101: 106246, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33316456

RESUMEN

BACKGROUND: Asthma prevalence, morbidity, and mortality disproportionately impact African American/Black (AA/B) and Hispanic/Latinx (H/L) communities. Adherence to daily inhaled corticosteroid (ICS), recommended by asthma guidelines in all but the mildest cases of asthma, is generally poor. As-needed ICS has shown promise as a patient-empowering asthma management strategy, but it has not been rigorously studied in AA/B or H/L patients or in a real-world setting. Design and Aim The PeRson EmPowered Asthma RElief (PREPARE) Study is a randomized, open-label, pragmatic study which aims to assess whether a patient-guided, reliever-triggered ICS strategy called PARTICS (Patient-Activated Reliever-Triggered Inhaled CorticoSteroid) can improve asthma outcomes in AA/B and H/L adult patient populations. In designing and implementing the study, the PREPARE research team has relied heavily on advice from AA/B and H/L Patient Partners and other stakeholders. Methods PREPARE is enrolling 1200 adult participants (600 AA/Bs, 600H/Ls) with asthma. Participants are randomized to PARTICS + Usual Care (intervention) versus Usual Care (control). Following a single in-person enrollment visit, participants complete monthly questionnaires for 15 months. The primary endpoint is annualized asthma exacerbation rate. Secondary endpoints include asthma control; preference-based quality of life; and days lost from work, school, or usual activities. Discussion The PREPARE study features a pragmatic design allowing for the real-world assessment of a patient-centered, reliever-triggered ICS strategy in AA/B and H/L patients. Outcomes of this study have the potential to offer powerful evidence supporting PARTICS as an effective asthma management strategy in patient populations that suffer disproportionately from asthma morbidity and mortality.


Asunto(s)
Asma , Negro o Afroamericano , Corticoesteroides , Adulto , Asma/tratamiento farmacológico , Hispánicos o Latinos , Humanos , Calidad de Vida
5.
Gac Med Mex ; 153(3): 415-422, 2017.
Artículo en Español | MEDLINE | ID: mdl-28763086

RESUMEN

This paper analyzes the articles published on chemicals and pharmaceuticals in the Periódico de la Academia de Medicina de Mégico. Through these publications it is possible to illustrate the transformation in the study of medical material of the era. At the same time, it shows discussions held by doctors and pharmacists about scientific news and analysis of local therapeutic resources.


Asunto(s)
Química/historia , Historia de la Farmacia , Publicaciones Periódicas como Asunto/historia , Historia del Siglo XIX , Humanos , México , Farmacéuticos/historia , Médicos/historia
6.
Front Pediatr ; 4: 2, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26835440

RESUMEN

INTRODUCTION: Hypospadias is a male congenital condition where the opening of the urethral meatus is not located in the typical anatomical position. It has been a challenge for empirical studies to ascertain the level of concordance of opinion among parents and urologists with regard to surgical outcomes according to hypospadias severity. MATERIALS AND METHODS: Parents of children who had undergone hypospadias repair were recruited for this study (n = 104). A set of questionnaires that included some items with Likert scale were created to evaluate postsurgical satisfaction by parents and urologists. SAHLSA-50, a validated instrument for adult Spanish-speaking adults, was used to assess health literacy. Cohen's kappa (κ) coefficient was used to assess interobserver agreement and Chi Square "Goodness of Fit" Test was used to determine probability of satisfaction. FINDINGS: Concordance on the level of satisfaction with surgical outcomes for Type cases I was slight (κ = 0.20; CI 95% 0-0.60), for Type II cases was moderate (κ = 0.54; CI 95% 0.13-0.94), and for Type III cases was substantial (κ = 0.62; CI 95% 0-0.56). However, the probability of satisfaction did not change according to severity (Chi Square "Goodness of Fit" Test; parents, p = 0.84; pediatric urologists, p = 0.92). These results cannot be explained by parental health literacy according to SAHLSA-50 test scores. CONCLUSION: The level of concordance of opinion among parents and urologists with regard to their level of satisfaction with surgical outcomes is related to hypospadias severity, whereby the greatest level of concordance of opinion was achieved among most severe cases. This study underscores the need for longer follow-up to properly assess satisfaction with hypospadias repair, especially for the less severe forms of the condition.

7.
Rev Med Inst Mex Seguro Soc ; 54(1): 96-105, 2016.
Artículo en Español | MEDLINE | ID: mdl-26820211

RESUMEN

From the second half of the 19th century, health disciplines went through an institutional and professional restructuring, which progressively altered the guild order that had characterized them to that point. In the case of Pharmacy, this process implied the generation of officially recognized spaces, as the chairs of Pharmacy and Medical Substance, founded during the Establecimiento de Ciencias Médicas (Establishment of Medical Sciences) (1833). In those spaces it was sought to institutionalize knowledge and modern practices related to Pharmacy. In this work we look over the first academic experience of the pharmaceutical community in that new space of instruction, based on the records belonging to the students enrolled in the Establecimiento de Ciencias Médicas from 1833 to 1865, year of the enrollment of the last generation. The information contained in those 163 records displays the way the pharmaceutical field was transformed, after the aforementioned restructuring. The reader will notice the diverse normativity, which regulated the joining of pharmacists to academic life (of which, until then, they were excluded). He will also realize how, among the first students enrolled in the Establecimiento de Ciencias Médicas, said normativity was broke in order to adapt it to the known ways of students and professors. Progressively, the guild instruction would be ousted by the institutional instruction (for example, the years of practice in the drugstores were rejected), so that the guild ways of teaching were changing to turn the pharmacist into an individual of institutional instruction.


Desde la segunda mitad del siglo XIX, las disciplinas de la salud atravesaron por una reestructuración institucional y profesional que progresivamente alteró el orden gremial que las agrupaba. Para el caso de la Farmacia, el proceso implicó la generación de espacios oficialmente reconocidos, como las propias cátedras de Farmacia y de Materia Médica, fundadas en el Establecimiento de Ciencias Médicas (1833). En esos espacios se buscó institucionalizar los saberes y las prácticas modernas relacionadas con la disciplina. En este trabajo se revisa la primera experiencia académica de la comunidad farmacéutica en su nuevo espacio de instrucción, a partir de los expedientes de los estudiantes inscritos en el Establecimiento de Ciencias Médicas de 1833, año de su fundación, a 1865, cuando se inscribió la última generación. La información de los 163 expedientes ilustra las transformaciones ocurridas en el ámbito farmacéutico luego de la reestructuración de su entorno profesional. El lector notará la diversa normatividad que pretendió regular el ingreso de los farmacéuticos a la vida académica de la que hasta entonces estaban excluidos y verá cómo entre los primeros inscritos al Establecimiento de Ciencias Médicas dicha normatividad fue transgredida para adaptarse a las formas ya conocidas por estudiantes y profesores. Progresivamente, la instrucción de tipo gremial sería desplazada por la institucional, al desdeñarse los años de práctica en las boticas, de manera que las formas gremiales de enseñanza se fueron transformando para hacer del farmacéutico un personaje de instrucción institucional.


Asunto(s)
Educación en Farmacia/historia , Historia de la Farmacia , Farmacéuticos/historia , Educación en Farmacia/métodos , Educación en Farmacia/organización & administración , Historia del Siglo XIX , Humanos , México , Farmacéuticos/organización & administración , Farmacia/organización & administración
8.
Dynamis ; 27: 263-85, 13-4, 2007.
Artículo en Español | MEDLINE | ID: mdl-18351167

RESUMEN

The Mexican Pharmaceutical Society was founded in 1871. Pharmacists in this Society organized and supported activities to develop their profession, including the preparation of a Mexican pharmacopela, promotion of the interests of pharmacists and improvement of the profession, and the creation of a unified legal framework for its practice. This society played a central role in the institutionalization of pharmacy as a profession and in the expansion of pharmacists into new areas, especially in relation to the transfer of pharmacy training from the National School of Medicine to the School of Chemical Sciences in 1919. when they took on a new identity as chemists.


Asunto(s)
Educación en Farmacia/historia , Sociedades Farmacéuticas/historia , Historia del Siglo XIX , Historia del Siglo XX , México , Farmacéuticos/historia , Farmacopeas como Asunto/historia
9.
Artículo en Español | HISA - História de la Salud | ID: his-14784

RESUMEN

Presenta la Sociedad Farmacéutica Mexicana, fundada en 1871. En su interior los farmacéuticos se organizaron y apoyaron las tareas necesarias para el desarrollo de su profesión: elaborar una farmacopea, velar por los intereses y el mejoramiento de la profesión, y reunir las leyes relativas al ejercicio de la farmacia.(AU)


Asunto(s)
Farmacéuticos/historia , Sociedades Farmacéuticas/historia , Farmacia/historia , México , Farmacopea
10.
In. Goldfarb, José Luiz; Ferraz, M rcia H. M. Anais do VII Semin rio Nacional de História da Ciência e da Tecnologia e da VII Reuniäo da Rede de Intercämbios para a História e a Epistemologia das Ciências Químicas e Biológicas. Säo Paulo, Sociedade Brasileira de História da Ciência, 2000. p.11-16, tab.
Monografía en Español | HISA - História de la Salud | ID: his-8840

RESUMEN

Tiene como propósito analizar los trabajos del Departamento de Observación del Hospital General de San Andrés de la Ciudad de México, instalado en 1800, donde, en medio de polémicas y controversias, se puso en pr ctica el brownismo, teoría que por entonces gozaba de gran popularidad tanto en Europa como en América.(AU)


Asunto(s)
Medicina de Hierbas/historia , México , Historia de la Medicina
11.
In. Goldfarb, José Luiz; Ferraz, Márcia H. M. Anais do VII Seminário Nacional de História da Ciência e da Tecnologia e da VII Reuniäo da Rede de Intercämbios para a História e a Epistemologia das Ciências Químicas e Biológicas. Säo Paulo, Sociedade Brasileira de História da Ciência, 2000. p.11-16, tab.
Monografía en Español | LILACS | ID: lil-319561

RESUMEN

Tiene como propósito analizar los trabajos del Departamento de Observación del Hospital General de San Andrés de la Ciudad de México, instalado en 1800, donde, en medio de polémicas y controversias, se puso en práctica el brownismo, teoría que por entonces gozaba de gran popularidad tanto en Europa como en América.


Asunto(s)
Medicina de Hierbas , Historia de la Medicina , México
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA